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2708Notwithstanding, the authors performed additional
secondary analysis and found that complete revas-
cularization (deﬁned as post-procedural obstruction
of <50% in all major epicardial coronary arteries)
conferred the best mortality outcome.
Given that we believe the labels in the central
illustration graph have been erroneously inverted
(patients undergoing successful CTO with/without
complete revascularization have higher cumulative
mortality?), in any case, these results deserve further
attention.
Indeed, despite statistical issues and the contro-
versial deﬁnition of complete revascularization,
mortality data of the complete revascularization
group (CTO and other major vessels) were quite
similar to those of patients undergoing partial revas-
cularization (only CTO), and completely overlapped
at 2.5 years. In fact, these results are in line with
previous large randomized trials, showing no clear
death or myocardial infarction beneﬁt from an initial
strategy of revascularization (3). In conclusion, in our
opinion, it appears premature to conclude that “the
improvement was greatest in patients when complete
revascularization was achieved.”*Alda Huqi, MD
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and Successful
RevascularizationGeorge et al. (1) recently published a database
review of treatment of attempted revascularization ofchronic total occlusion in the United Kingdom. They
have compiled a useful analysis of the outcomes and
feasibility of attempted revascularization of chronic
total occlusions. The paper is informative as a
descriptive study. However, analyzing mortality on
the basis of successful versus failed recanalization is
not a fair assessment of the beneﬁt of the procedure.
The analysis is performed on the basis of an outcome
variable (procedural success) rather than on an input
variable (attempted revascularization).
It is not logical to suggest that a procedure is
beneﬁcial simply because those with failed pro-
cedures had worse outcomes than those with suc-
cessful procedures. It is not surprising in any ﬁeld of
endeavor that success is associated with better
outcome than failure. One should not imply that a
cancer drug is beneﬁcial simply because patients who
responded to the drug did better than those that did
not; one cannot imply beneﬁt of revascularization
because those with successful interventions do better
than those with failed interventions.
If we are to conclude that these groups (procedural
success and procedural failure) are comparable (i.e.,
have similar disease burdens) then we should have
expected similar procedural outcomes. However,
procedural failure is more likely due to the com-
plexity of the underlying disease. It is quite likely that
the difference in mortality observed is explained by
differences in the severity of the underlying disease
or other comorbidities rather than by any beneﬁt of
the procedure.
The authors do not make any mention of the bias
introduced by inferring beneﬁt of a procedure by
comparing outcomes of failure versus success, and
Dr. Mahmud, in the accompanying editorial (2), only
brieﬂy suggests there might be an interaction
between the underlying disease and outcome. In this
setting, there is no relevant group for comparison of
revascularization beneﬁt, as there is no group that did
not have attempted revascularization. In the absence
of randomization, an alternative would be to try to
match patient with chronic occlusion who did not
undergo attempted revascularization. In any event,
to establish beneﬁt of the procedure, there must be
some comparison group that did not undergo the
procedure. In the absence of a relevant control or
comparison group, they should not suggest that the
procedure is beneﬁcial; they can only state that
failure is worse than success.
Absent relevant comparison groups, this study
stands as a very detailed description of outcomes in
a large population of subjects undergoing revas-
cularization of chronically totally occluded coronary
arteries, but it does not establish a mortality beneﬁt.
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Elective Chronic Total
Coronary Occlusion
AngioplastyIn the paper by George et al. (1), regarding the clinical
outcome after chronic total occlusion (CTO) percu-
taneous coronary intervention (PCI), the methods
have been described with insufﬁcient details and no
data are provided about the indication to PCI and the
viability of the myocardial territory supplied by the
CTO vessel (1). Moreover, beyond the characteristics
of the medical treatment after PCI that were un-
known, patients with successful PCI had nonuniform
procedural treatment with a substantial minority of
patients receiving bare-metal stents or no stent. All
these variables might have confounded the results
considering the strong impact on survival of optimal
medical treatment and drug-eluting stents after CTO
PCI. The authors revealed a survival beneﬁt after CTO
PCI success, and a greater survival improvement in
patients who received a complete revascularization.
It should have been outlined that patients with a
CTO and single-vessel disease have a very low mor-
tality rate and it is likely that the outcome cannot
be improved by successful PCI. Conversely, the
beneﬁt of a complete revascularization is easily
revealed in patients with at least 1 CTO and multi-
vessel disease. The link between completeness of
revascularization and improved survival just in pa-
tients with CTO and multivessel disease was already
demonstrated by 2 key studies that are not com-
mented on or quoted by the authors (2,3). Finally, it
seems unlikely that the ongoing EuroCTO (European
Chronic Total Occlusion) study comparing CTO PCIwith optimal medical therapy alone will deﬁnitely
support the indication to CTO revascularization,
considering the very low enrollment rate of this
study and the subsequent biased patient selection,
and the strong rationale of revascularization of
a CTO vessel supplying a large amount of viable
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2013;61:282–94.REPLY: Long-Term Follow-Up of Elective
Chronic Total Coronary Occlusion AngioplastyWe thank the readers of the Journal for their
thoughtful comments about our paper (1). We carried
out a retrospective analysis of registry data concern-
ing chronic total occlusion (CTO) procedures. In
keeping with other International Procedural Regis-
tries, no data exist in the British Cardiovascular
Intervention Society dataset for patients in whom
revascularization was not attempted. In view of this,
we have been careful not to attribute causality; we
have simply described the association. This was not a
randomized trial.
Dr. Huqi and colleagues suggest that our work is
consistent with previous work by Boden et al. (2),
which examined medical management versus percu-
taneous coronary intervention (PCI). That study is not
representative of our patient population, as they
excluded patients whose coronary anatomy was not
considered suitable for successful PCI (as is the case
